Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
Study Details
Study Description
Brief Summary
This study aims to analyse baseline data on IS in order to monitor the possibility of increased risk of IS in children aged <12 months after introduction of the Rotarix vaccination in Japan.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Case Group Children aged < 12 months presenting with IS and covered by the Japan Medical Data Centre Company Limited (JMDC), Tokyo referred to as the JMDC Medical Data Bank (JMDC-MDB). |
Other: Data collection
Data source will be the Japan Medical Data Centre Company Limited (JMDC) - JMDC Medical Data Bank (JMDC-MDB) database. Aggregated data (age in months and years and gender) for all subjects recorded in the database and subject-level data for IS cases will be extracted from the database. This database will be reviewed to extract data for the period between January 2005 and April 2011. Cases of IS will be identified using the International Classification of Diseases-10 (ICD-10) diagnostic codes, examination codes and procedural codes.
|
Outcome Measures
Primary Outcome Measures
- Occurrence of IS in subjects aged < 12 months [Between January 2005 and April 2011 (6 years)]
- Occurrence of age-specific and gender-specific incidence of IS among subjects aged < 12 months in Japan [Between January 2005 and April 2011 (6 years)]
Secondary Outcome Measures
- Number of IS cases hospitalized more than once among subjects aged < 12 months. [Between January 2005 and April 2011 (6 years)]
- Occurrence of IS cases by calendar months and year among subjects aged < 12 months [Between January 2005 and April 2011 (6 years)]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
A male or female infant aged < 12 months at the time of IS diagnosis and affiliated to the JMDC-MDB database.
-
An IS case should be identified as per the ICD-10 diagnostic code-K56.1 (any-field listed), examination codes, and procedural codes.
Exclusion Criteria:
Not applicable
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- GlaxoSmithKline
Investigators
- Study Director: GSK Clinical Trials, GlaxoSmithKline
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 116259